Top compounds associated with response to VAMP3


Feature Type Standardized
Nominal ANOVA
mRNA darinaparsin CTRPv2 pan-cancer AAC -0.2 0.002
mRNA lovastatin CTRPv2 pan-cancer AAC 0.14 0.002
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.13 0.002
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.002
mRNA Pazopanib GDSC1000 pan-cancer AAC 0.13 0.002
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.13 0.002
mRNA AZ-3146 CTRPv2 pan-cancer AAC -0.13 0.002
mRNA avicin D CTRPv2 pan-cancer AAC 0.2 0.002
mRNA PDMP CTRPv2 pan-cancer AAC -0.14 0.002
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
Download CSV